Cogent Biosciences, Inc.
COGTNasdaqCIK 1622229HealthcareFiscal year ends Dec 31
Reports and events: 156 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0220:11 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-380194 |
| 2026-08-1021:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-342695 |
| 2026-08-1020:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342393 |
| 2026-08-1012:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341315 |
| 2026-06-1120:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267566 |
| 2026-05-0512:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-205170 |
| 2026-05-0512:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205124 |
| 2026-04-2320:30 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001193125-26-173834 |
| 2026-03-3101:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-038056 |
| 2026-02-1714:24 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-053334 |
| 2026-02-1713:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-053131 |
| 2026-01-2201:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-005917 |
| 2025-12-0821:05 ET | 8-K | 8.01 Other events | 0001193125-25-311217 |
| 2025-11-1821:09 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-286158 |
| 2025-11-1721:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-113219 |
| 2025-11-1311:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278679 |
| 2025-11-1013:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-273315 |
| 2025-11-0721:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272334 |
| 2025-11-0314:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-261797 |
| 2025-09-1120:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-201353 |
| 2025-08-0512:46 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102440 |
| 2025-08-0512:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102433 |
| 2025-07-1420:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-067760 |
| 2025-07-1012:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-157390 |
| 2025-07-0711:15 ET | 8-K | 8.01 Other events | 0001193125-25-155811 |
| 2025-06-1112:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-138813 |
| 2025-06-0512:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-135337 |
| 2025-05-0613:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064005 |
| 2025-05-0612:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063987 |
| 2025-04-2220:31 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001193125-25-089237 |
| 2025-02-2513:38 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026115 |
| 2025-02-2513:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026103 |
| 2024-12-0921:01 ET | 8-K | 8.01 Other events | 0001193125-24-273393 |
| 2024-11-1214:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124712 |
| 2024-11-1213:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124653 |
| 2024-09-0312:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-211584 |
| 2024-08-0612:40 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091229 |
| 2024-08-0612:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091220 |
| 2024-06-2712:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-169756 |
| 2024-06-1310:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-160264 |
| 2024-06-0520:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-155116 |
| 2024-05-0712:26 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053977 |
| 2024-05-0712:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053974 |
| 2024-04-2320:32 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001193125-24-107124 |
| 2024-04-0122:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-083703 |
| 2024-03-2720:37 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-078864 |
| 2024-03-2212:33 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-074628 |
| 2024-02-2614:13 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-019770 |
| 2024-02-2613:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-019754 |
| 2024-02-1623:55 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-038694 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.